Pembro{wPTX{wCBDCA (NAC1)
€–Ϊ–Ό Šξ€—Κ ’PˆΚ }ަ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 @ @ @ @ @ @ @
‘S‘ΜƒXƒPƒWƒ…[ƒ‹ œ ‹x ‹x ‹x ‹x ‹x ‹x -- ‹x ‹x ‹x ‹x ‹x ‹x -- ‹x ‹x ‹x ‹x ‹x ‹x @ @ @ @ @ @ @
ƒLƒCƒgƒ‹[ƒ_ 200 ‚‚‡ š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒpƒNƒŠƒ^ƒLƒZƒ‹ 80 mg/‡u š @ @ @ @ @ @ š @ @ @ @ @ @ š @ @ @ @ @ @ @ @ @ @ @ @ @
ƒJƒ‹ƒ{ƒvƒ‰ƒ`ƒ“ 0 š @ @ @ @ @ @ š @ @ @ @ @ @ š @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
y’ˆΣƒ`ƒ…ƒEƒCŽ–€ƒWƒRƒEz
ƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒu@p‘O‰»Šw—Γ–@ƒWƒ…ƒcƒ[ƒ“ƒJƒKƒNƒŠƒ‡ƒEƒzƒE